Pretzel Therapeutics

Series-A
pretzeltx.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Series-A
Last Announced Sep 12, 2022
Investors Undisclosed
Decision Makers 6 Verified

About Pretzel Therapeutics

Develops medicines targeting cellular energetics to treat neurological and rare diseases.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website pretzeltx.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Series-A announced

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Pretzel Therapeutics.

Funding History

1 Round
Series-A · Sep 12, 2022

Founders & Leadership

2

Gabriel Martinez

Chief Scientific Officer & Co-Founder

Work email & phone locked Unlock →

Michal Minczuk

Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts